The High Cost of Medication: How a Copay Card Assisted Until It No Longer Did
-
By
-
Elisabeth Rosenthal
-
February 27, 2026
By
Elisabeth Rosenthal
February 27, 2026
by Elisabeth Rosenthal
February 27, 2026
Approval expands risankizumab use to pediatric plaque psoriasis and psoriatic arthritis and includes a new 55-mg prefilled syringe for weight-based dosing in patients weighing less than 40 kg.
June 29, 2026
A phase 3b trial tests ixekizumab plus tirzepatide in adults with moderate-to-severe plaque psoriasis and obesity or overweight.
February 18, 2026
Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.
by Paula Span
February 4, 2026